BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 11303275)

  • 1. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid.
    Babcock HM; Ritchie DJ; Christiansen E; Starlin R; Little R; Stanley S
    Clin Infect Dis; 2001 May; 32(9):1373-5. PubMed ID: 11303275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin-resistant Enterococcus faecium endocarditis in a premature infant successfully treated with linezolid.
    Ang JY; Lua JL; Turner DR; Asmar BI
    Pediatr Infect Dis J; 2003 Dec; 22(12):1101-3. PubMed ID: 14688576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of vancomycin-resistant Enterococcus faecium endocarditis with linezolid in a renal transplant recipient with human immunodeficiency virus infection.
    Archuleta S; Murphy B; Keller MJ
    Transpl Infect Dis; 2004 Sep; 6(3):117-9. PubMed ID: 15569227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature.
    Zeana C; Kubin CJ; Della-Latta P; Hammer SM
    Clin Infect Dis; 2001 Aug; 33(4):477-82. PubMed ID: 11462183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin).
    McNeil SA; Clark NM; Chandrasekar PH; Kauffman CA
    Clin Infect Dis; 2000 Feb; 30(2):403-4. PubMed ID: 10671355
    [No Abstract]   [Full Text] [Related]  

  • 6. Linezolid therapy of vancomycin-resistant Enterococcus faecium experimental endocarditis.
    Patel R; Rouse MS; Piper KE; Steckelberg JM
    Antimicrob Agents Chemother; 2001 Feb; 45(2):621-3. PubMed ID: 11158767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocarditis due to vancomycin-resistant Enterococcus raffinosus successfully treated with linezolid: case report and review of literature.
    Jasovich A; Ganaha MC; Ebi C; GarcĂ­a RD; Blanco MA; Lopardo H
    Rev Argent Microbiol; 2008; 40(4):204-7. PubMed ID: 19213241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium.
    Till M; Wixson RL; Pertel PE
    Clin Infect Dis; 2002 May; 34(10):1412-4. PubMed ID: 11981739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinupristin-dalfopristin and linezolid: evidence and opinion.
    Eliopoulos GM
    Clin Infect Dis; 2003 Feb; 36(4):473-81. PubMed ID: 12567306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Linezolid for the treatment of newborns infected with vancomycin-resistant Enterococcus faecium].
    Berberian G; Castro G; Fistolera S; Travaglianti M; Lopardo H; Mastroianni A; Rosanova MT
    Rev Argent Microbiol; 2009; 41(1):34-8. PubMed ID: 19391524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linezolid- and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin.
    Jenkins I
    J Hosp Med; 2007 Sep; 2(5):343-4. PubMed ID: 17935250
    [No Abstract]   [Full Text] [Related]  

  • 12. Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections.
    Raad I; Hachem R; Hanna H; Afif C; Escalante C; Kantarjian H; Rolston K
    J Antimicrob Chemother; 2004 Apr; 53(4):646-9. PubMed ID: 14998986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinupristin-dalfopristin versus linezolid for the treatment of vancomycin-resistant Enterococcus faecium bacteraemia: efficacy and development of resistance.
    Chong YP; Lee SO; Song EH; Lee EJ; Jang EY; Kim SH; Choi SH; Kim MN; Jeong JY; Woo JH; Kim YS
    Scand J Infect Dis; 2010 Jul; 42(6-7):491-9. PubMed ID: 20524781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin-resistant Enterococcus faecium osteomyelitis: successful treatment with quinupristin-dalfopristin.
    Summers M; Misenhimer GR; Antony SJ
    South Med J; 2001 Mar; 94(3):353-5. PubMed ID: 11284529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
    Seedat J; Zick G; Klare I; Konstabel C; Weiler N; Sahly H
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4217-9. PubMed ID: 16982791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy.
    Le J; Bookstaver PB; Rudisill CN; Hashem MG; Iqbal R; James CL; Sakoulas G
    Ann Pharmacother; 2010 Dec; 44(12):2001-6. PubMed ID: 21119097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin.
    Noskin GA; Siddiqui F; Stosor V; Kruzynski J; Peterson LR
    Clin Infect Dis; 1999 Mar; 28(3):689-90. PubMed ID: 10194104
    [No Abstract]   [Full Text] [Related]  

  • 18. Short course of linezolid treatment for vancomycin-resistant Enterococcus faecium meningitis.
    Tsai TN; Wu CP; Peng MY; Giian CF; Lee SY; Lu JJ
    Int J Clin Pract; 2006 Jun; 60(6):740-1. PubMed ID: 16805761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia.
    Erlandson KM; Sun J; Iwen PC; Rupp ME
    Clin Infect Dis; 2008 Jan; 46(1):30-6. PubMed ID: 18171210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report.
    Swoboda S; Fritz S; Martignoni ME; Feldhues RA; Hoppe-Tichy T; Buchler MW; Geiss HK
    J Antimicrob Chemother; 2005 Oct; 56(4):787-9. PubMed ID: 16143710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.